← Back to Search

Soy-based Formula

3: Soy formula for Newborns

Phase 2 & 3
Waitlist Available
Research Sponsored by Abbott Nutrition
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 35 days
Awards & highlights

Study Summary

The objective of this study is to assess the comparative gastrointestinal (GI) tolerance of normal term infants to two experimental soy-based formulas, relative to a commercially available soy-based formula.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~35 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 35 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Gastrointestinal tolerance from Study Visit 1 to Study Visit 3 at 35 days of age.
Secondary outcome measures
Additional gastrointestinal measures of tolerance from Study Visit 1 to Study Visit 3 at 35 days of age

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: 3: Soy formulaExperimental Treatment1 Intervention
experimental soy formula #2
Group II: 1: Soy formulaExperimental Treatment1 Intervention
experimental soy formula #1
Group III: 2: Soy FormulaActive Control1 Intervention
Commercially available soy formula

Find a Location

Who is running the clinical trial?

Abbott NutritionLead Sponsor
168 Previous Clinical Trials
33,350 Total Patients Enrolled
John Lasekan, PhDStudy ChairAbbott Nutrition
3 Previous Clinical Trials
158 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Comparative Gastrointestinal Tolerance of Various Infant Formulas in Healthy Term Infants
2008. "Comparative Gastrointestinal Tolerance of Various Infant Formulas in Healthy Term Infants". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00798382.
~9 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top